Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GENOMIC VALLEY BIOTECH LTD.

NSE : NABSE : 539206ISIN CODE : INE574D01010Industry : AgricultureHouse : Private

BSE63.131.03 (+1.66 %)

PREV CLOSE ( ) 62.10

OPEN PRICE ( ) 62.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 897

TODAY'S LOW / HIGH ( )62.10 63.34

52 WK LOW / HIGH ( ) 28.36108.15

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-07 1994

Management Info

- Chairman Yogesh Agrawal - Managing Director

Registered Office

Address 4 Km Stone, Berri Chharra Road,P O Tandaheri,Tehsil- Bahadurgarh,
Jhajjar Dist,
Haryana-124507

Phone 9811341542

Email genomicvalley@gmail.com

Website www.genomicvalley.com

Registrars Details

Beetal Financial & Computer Services (P) Ltd

Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi

Listing : BSE

NEWS

18Oct Genomic Valley Biotech informs about d
Genomic Valley Biotech has informed that the exchange has received the d..

03Oct Genomic Valley Biotech submits board m
Genomic Valley Biotech has informed that the meeting of Board of Directo..

19Sep Genomic Valley Biotech informs about d
Genomic Valley Biotech has informed that the exchange has received the d..

26Aug Genomic Valley Biotech informs about d
Genomic Valley Biotech has informed that the exchange has received the d..

01Aug Genomic Valley Biotech informs about
Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclo..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL 24
Net Profit	1.56	0.15
Gross Profit	1.56	0.15
Operating Profit	1.56	0.16
Net Sales	2.2	1.65

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Venkys India (BSE) 1709.80 (0.55%)	M.Cap ( in Cr)2408.65
Nath Bio-Genes (BSE) 168.10 (3.57%)	M.Cap ( in Cr)319.46
Indo US Bio-Tech (BSE) 173.25 (3.13%)	M.Cap ( in Cr)347.40
Tierra Agrotech (BSE) 43.81 (1.88%)	M.Cap ( in Cr)287.37
Agri-Tech (India) (BSE) 142.65 (0.56%)	M.Cap ( in Cr)84.73

Shareholding Pattern

	NON-INSTITUTION	53.22%
	PROMOTERS	46.78%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

GENOMIC VALLEY BIOTECH LTD.